← Back to Dashboard

MANKIND Mankind Pharma Ltd. — Smart-Money Activity, F&O Buildup & Bulk Deals

Sector: Healthcare
₹ 2,380.00
-4.80%
1-year price · range ₹1,988–₹2,584

Live setups screens MANKIND is on right now — tap to see every stock matching

Smart Money Verdict synthesis of derivatives, deals, and promoter files

No significant institutional activity detected
Derivative metrics and institutional flows are quiet. No recent bulk deals or insider disclosures have been reported.

Analysis what the data is telling us about MANKIND

In the last completed session, Mankind Pharma Ltd. closed -0.47% with futures open interest moving +0.3%. Positioning is neutral — neither side is decisively adding or unwinding right now. The option PCR of 0.82 is balanced — no clear directional preference from option writers. Max-pain strike at ₹2,480 sits 4.2% above the current price, a mild magnet near expiry.

There have been no notable bulk or block deals from FIIs, mutual funds, or insurance companies in Mankind Pharma Ltd. over the last 30 sessions.

Putting it together, the smart-money picture for Mankind Pharma Ltd. is balanced between accumulation and distribution forces.

F&O Positioning EOD derivatives setup

Buildup Class
Neutral
bias: neutral
Futures OI
3,167,000
+10000 (+0.3%)
Option PCR (OI)
0.82
neutral option setup
Max Pain Strike
₹ 2,480
writer loss minimized strike

Quote Details key metrics & weights

Previous Close
₹ 2,500.00
yesterday's EOD close
Index Contribution
—
not a Nifty 50 constituent
Traded Volume
783,247
live shares traded today
Upcoming Earnings
—
no report scheduled

Technical Snapshot as of 2026-10-07 close · from 400 sessions of price history

RSI (14)
57.3
neutral momentum
52-Week High
₹ 2,642.00
-5.4% from high
52-Week Low
₹ 1,909.70
+30.9% above low
200-DMA
₹ 2,305.47
+8.4% · above trend
50-DMA
₹ 2,406.68
+3.9% from 50-DMA
1-Year Return
+1.8%
1M +8.3%

Key Fundamentals headline ratios · Healthcare

P/E (TTM)
49.1
price / earnings
P/B
6.1
price / book
ROE
—
return on equity
Market Cap
₹ 100,159 Cr
total market value
Dividend Yield
0.08%
trailing yield
EPS (TTM)
₹ 49.42
earnings per share

Fundamental ratios sourced from public market data, refreshed periodically; verify against company filings before relying on them.

Institutional Deals last 30 sessions (bulk & block)

No institutional bulk or block deals recorded for this stock in the last 30 sessions.

Broker Calls as reported · last 120 days

DateBrokerageCallTargetSource
2026-08-20 InCred Initiate — NDTV Profit
2026-08-19 InCred Initiate — NDTV Profit
2026-08-18 InCred Initiate — NDTV Profit
2026-08-17 InCred Initiate — NDTV Profit
2026-08-02 InCred Initiate — NDTV Profit
2026-08-01 InCred Initiate — NDTV Profit
2026-07-30 InCred Initiate — NDTV Profit
2026-07-29 InCred Initiate — NDTV Profit
2026-07-28 InCred Initiate — NDTV Profit
2026-07-27 InCred Initiate — NDTV Profit
2026-07-26 InCred Initiate — NDTV Profit
2026-07-25 InCred Initiate — NDTV Profit
Analyst calls as reported in the business press — collected and matched by Strota, not recommendations. Targets are the reporting publication's figures.

Insider & Promoter Filings last 60 days

No insider disclosures filed for this stock in the last 60 days.

Option Chain Ladder nearest expiry 2026-10-27 · spot 2,500 · EOD 2026-10-07

Option writers expect range between 2,300 and 2,500 — +0.0% upside, -8.0% downside.
unbalanced
Call OI (writers) Strike Put OI (writers)
0
IV 17% Δ 0.91 θ -0.8 ν 1
2380
11,000 +1k
IV 29% Δ -0.20 θ -1.1 ν 2
42,750
IV 34% Δ 0.73 θ -2.0 ν 2
2400
56,750 -3k
IV 29% Δ -0.24 θ -1.2 ν 2
3,250
IV 24% Δ 0.76 θ -1.4 ν 2
2420
44,250 +1k
IV 29% Δ -0.28 θ -1.3 ν 2
4,000
IV 27% Δ 0.69 θ -1.7 ν 2
2440
12,750
IV 27% Δ -0.32 θ -1.3 ν 2
64,250
IV 24% Δ 0.65 θ -1.6 ν 2
2460
101,000 +3k
IV 28% Δ -0.37 θ -1.4 ν 2
21,000 +0k
IV 23% Δ 0.60 θ -1.6 ν 2
2480 MP
46,500 -1k
IV 28% Δ -0.42 θ -1.5 ν 2
133,750 +14k
IV 24% Δ 0.54 θ -1.7 ν 2
2500 R
83,000 -8k
IV 29% Δ -0.47 θ -1.5 ν 2
55,250 -3k
IV 25% Δ 0.48 θ -1.7 ν 2
2520
47,000 +1k
IV 29% Δ -0.51 θ -1.5 ν 2
70,000 +10k
IV 25% Δ 0.42 θ -1.6 ν 2
2540
500 +0k
IV 30% Δ -0.56 θ -1.5 ν 2
14,750 +1k
IV 25% Δ 0.37 θ -1.6 ν 2
2560
0
IV 43% Δ -0.56 θ -2.3 ν 2
27,000
IV 25% Δ 0.32 θ -1.4 ν 2
2580
1,500
IV 40% Δ -0.60 θ -2.0 ν 2
122,250 +2k
IV 26% Δ 0.28 θ -1.4 ν 2
2600
6,500
IV 39% Δ -0.64 θ -1.9 ν 2
6,500 +1k
IV 26% Δ 0.24 θ -1.4 ν 2
2620
0
IV 94% Δ -0.54 θ -5.3 ν 2

Chain Interpretation

Spot Underlying 2,500.00
Key Resistance (R) 2,500
Key Support (S) 2,300
Max Pain Strike (MP) 2,480
Concentrations of Option open interest show strong barrier levels. Option writers defend these levels, especially heading into monthly derivatives expiry.

Strategy Builder multi-leg payoff for MANKIND options · 2026-10-27 expiry

Underlying: MANKIND · Spot: ₹ 2,500.00 · Expiry: 2026-10-27 · Lot: 250

Legs

Side
Type
Strike
Qty
Premium
Net premium—
Max profit—
Max loss—
Breakevens—
Position Delta—
Position Theta/day—
Position Vega/1% IV—

Payoff at expiry

Latest News recent coverage from Reuters, Simply Wall St, MT Newswires and others

No recent news articles found for this stock.

MANKIND — frequently asked questions

What is the Mankind Pharma Ltd. share price today?

MANKIND is trading at ₹2,380.00 (-4.80% vs previous close), per the latest update on this page.

What is the P/E ratio of Mankind Pharma Ltd.?

MANKIND (Mankind Pharma Ltd.) has a trailing twelve-month P/E ratio of 49.1.

What is the market cap of Mankind Pharma Ltd.?

MANKIND has a market capitalisation of approximately ₹100,159 crore.

Is MANKIND near its 52-week high?

MANKIND is trading -5.4% from its 52-week high of ₹2,642.00 as of 2026-10-07.

What is the RSI of MANKIND?

The 14-day RSI of MANKIND is 57.3, which is considered neutral.

Is MANKIND above its 200-day moving average?

MANKIND is trading above its 200-DMA of ₹2,305.47 (+8.4% away).

What is the F&O buildup in MANKIND?

The latest end-of-day derivatives data classifies MANKIND as Neutral (bias: neutral), based on the day's combined price and open-interest change.

What is the max pain and PCR for MANKIND options?

MANKIND's option-chain max pain strike is ₹2,480 and its put-call ratio (OI) is 0.82, from the latest end-of-day option chain.

Are FIIs or big investors buying MANKIND?

Strota tracks every bulk and block deal in MANKIND with named buyers and sellers, plus promoter and insider filings — the tables on this page list the most recent institutional activity as disclosed to the exchanges.

What is the latest broker call on MANKIND?

The most recent analyst call reported in the press is InCred: Initiate (2026-08-20). The Broker Calls section on this page lists reported calls from the last 120 days with links to the original reports.